Cite

HARVARD Citation

    Yang, T. et al. (2022). Serum prolactin level as a predictive factor for abiraterone response in patients with metastatic castration‐resistant prostate cancer. Prostate. 82 (13), pp. 1284-1292. [Online]. 
  
Back to record